CDC: 1.8M Covid Cases and 143 Child Deaths Justifies Exposing 28M to a Faulty Product
If you’re pondering whether to consent to the covid shot for your child, please consider all the information available, not just the insane vaccine orthodoxy that’s bombarding you from every angle, Sensitive Soul. Way back in 2019, BC (Before Covid) it was accepted science and kitchen table wisdom that children naturally build robust and protective immune systems by having them “taxed” and “tuned up” over and over and over again.
In 2021, AC (After Covid) the mass hysteria around a virus the discriminates against the ill, the obese and the elderly, will soon be mandated for healthy children, who are at zero risk. Children who get infected typically exhibit mild symptoms, don’t spread it to other children or adults, and fully recover 99.99% of the time. Most children contract the infection at home from adults. Once infected, their immune system recognizes the virus and mounts an all-out defense which, after recovery, affords them (and us) protection from both the original strain as well as known and unknown variants. The experimental shot hijacks your child’s natural immune system, making it more fragile and less protective against the novel viruses that “leaky” vaccines drive.
There’s no data on long term adverse effects, but data released Friday by the Centers for Disease Control and Prevention (CDC) showed that between Dec. 14, 2020, and Oct. 22, 2021, a total of 837,595 adverse events following COVID vaccines were reported to the Vaccine Adverse Event Reporting System (VAERS).
Why risk injecting your child with a faulty product that could harm them when they are at such low risk of dying from covid?
Please consider the following information written by Megan Redshaw from The Defender before you decide:
The U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID vaccine for children 5 to 11 years old. During Tuesday’s meeting, the Vaccines and Related Biological Products Committee heard evidence from Pfizer and regulators, and listened to concerns raised by multiple scientists and physicians. Based on CDC data presented during the meeting, among children 5 to <12 years of age, there have been approximately 1.8 million confirmed and reported COVID cases since the beginning of the pandemic, and only 143 COVID-related deaths in the U.S. through Oct. 14.
Pfizer provided safety data on two study cohorts of children ages 5 to 11, both of roughly equal size. The first group was followed for only about two months, the second for only two-and-a-half weeks. Pfizer said “post-vaccination myocarditis/pericarditis” in participants 5 to <12 years of age will not be studied until after the vaccine is authorized for children.
Pfizer vaccine ‘failed any reasonable risk-benefit calculus in connection with children,’ says Brian Dressen, Ph.D., who is one of the scientists who testified Tuesday during the FDA advisory committee’s 8-hour hearing. He noted that “incomplete data from underpowered trials were insufficient to predict rates of severe and long-lasting adverse reactions.”
Dressen urged the committee to reject the EUA modification and direct Pfizer to perform trials that decisively demonstrate the benefits outweigh the risks for children. Dressen’s wife was severely injured last November after receiving her first and only dose of a COVID vaccine administered during a clinical trial.
“Because study protocol requires two doses, she was dropped from the trial, and her access to the study app deleted,” Dressen said. “Her reaction is not described in the recently released clinical trial report — 266 participants are described as having an adverse event leading to discontinuation, with 56 neurological reactions tallied.”
Paul Elias Alexander, Ph.D, also of the Defender writes: “It is clear that children are at very low risk of spreading the infection to other children, of spreading the virus to adults (as seen in household transmission studies), or of taking the virus home or becoming ill and/or dying — this is settled scientific global evidence.
Children are less at risk of developing severe illness, and also are far less susceptible and likely to spread and drive SARS-CoV-2 (references 1, 2, 3, 4)This implies that any mass injection/inoculation, or even clinical trials, on children with such near-zero risk of spread and illness/death is contraindicated, unethical and potentially associated with significant harm.
A team of Johns Hopkins researchers recently reported that when they looked at a group of about 48,000 children in the U.S. infected with the virus, they found no (zero) COVID deaths among the healthy children.
Dr. Marty Makary indicated his team worked with the nonprofit FAIR Health to analyze approximately 48,000 children under 18 diagnosed with COVID in health-insurance data from April to August 2020. After studying comprehensive data on thousands of children, the team found a mortality rate of zero among children without a pre-existing medical condition such as leukemia.
With this background, we knew of the very low risk to children in the first place, but wanted scientific documentation (molecular/biological) of why this low risk existed, to help support our argument against COVID injections in our children — especially given evidence from Wisconsin, based on a study of 36 counties, showing vaccinated persons can shed/spread the virus.
The study showed 158 of 232 (68%) of COVID cases occurred in unvaccinated individuals, and 156 of 225 (69%) occurred in fully vaccinated and symptomatic individuals. The Wisconsin study suggests the current vaccines are not working with the predominant Delta variant, and there is no difference between the vaccinated and unvaccinated (symptomatic) in becoming infected, colonizing, carrying and transmitting COVID. This is not a theoretical risk — this data provide a clear real risk example.
Photo from The Defender
https://childrenshealthdefense.org/defender/paul-elias-alexander-children-zero-risk-covid/
https://adc.bmj.com/content/105/7/618
https://www.medrxiv.org/content/10.1101/2021.07.31.21261387v4.full.pdf